The FDA first approved eculizumab for use in adult patients with generalized myasthenia gravis in 2017, before expanding the ...

The price you pay for Soliris may depend on factors such as whether you have health insurance. Financial assistance may be available to help you with the cost of Soliris. your treatment plan your ...

Soliris contains the active ingredient eculizumab and is a biologic drug. This means it’s made from parts of living organisms. Soliris comes in biosimilar forms. Biosimilars are like generic ...

Myasthenia gravis (MG) results from autoimmune antibodies against the post-synaptic neuromuscular junction with three major ...

与此同时，欧洲麻疹疫情的急剧恶化引发了广泛关注。根据欧洲疾病预防控制中心（ECDC）公布的数据，自2024年初以来，麻疹病例在欧盟及邻国飙升至32,000多例，其中罗马尼亚成为重灾区，病例累积达到27,568例，疫情已造成至少19人死亡。紧随其后的是意大利和德国，所有国家均未能幸免。ECDC警告，麻疹疫情的传播高峰通常出现在上半年，预计未来几个月病例数可能继续增加。值得注意的是，绝大多数感染者未接 ...

Generalised myasthenia gravis (gMG) is a chronic disorder in which the body's immune system mistakenly targets the neuromuscular junctions—areas where nerves signal muscles to move. This ...

根据美国肌肉萎缩症协会（MDA）发布的新闻稿，FDA已批准扩大依库珠单抗（商品名：舒立瑞）的适应症，将抗乙酰胆碱受体（AChR）抗体阳性的6岁及以上全身型重症肌无力（gMG）儿童患者纳入其中，这使得依库珠单抗成为首个也是唯一一个治疗gMG儿童患者的药物。依库珠单抗是一种人源化单克隆抗体，其最初被批准用于治疗AChR抗体 ...

Patients with diabetic macular edema previously treated with a ranibizumab biosimilar in India experience comparable safety and efficacy after being switched to another ranibizumab biosimilar, ...